Abbreviated Magnetic Resonance Imaging for HCC Surveillance.
作者信息
Vietti Violi Naik, Fowler Kathryn J, Sirlin Claude B, Taouli Bachir
机构信息
Department of Radiology Lausanne University Hospital Lausanne Switzerland.
Liver Imaging Group Department of Radiology UC San Diego Medical Center San Diego CA.
出版信息
Clin Liver Dis (Hoboken). 2021 Apr 13;17(3):133-138. doi: 10.1002/cld.1016. eCollection 2021 Mar.
Abstract
摘要
相似文献
1
Abbreviated Magnetic Resonance Imaging for HCC Surveillance.
Clin Liver Dis (Hoboken). 2021 Apr 13;17(3):133-138. doi: 10.1002/cld.1016. eCollection 2021 Mar.
2
Noncontrast magnetic resonance imaging versus ultrasonography for hepatocellular carcinoma surveillance (MIRACLE-HCC): study protocol for a prospective randomized trial.
BMC Cancer. 2018 Sep 24;18(1):915. doi: 10.1186/s12885-018-4827-2.
3
Diagnostic per-patient accuracy of an abbreviated hepatobiliary phase gadoxetic acid-enhanced MRI for hepatocellular carcinoma surveillance.
AJR Am J Roentgenol. 2015 Mar;204(3):527-35. doi: 10.2214/AJR.14.12986.
4
Comparison of biannual ultrasonography and annual non-contrast liver magnetic resonance imaging as surveillance tools for hepatocellular carcinoma in patients with liver cirrhosis (MAGNUS-HCC): a study protocol.
BMC Cancer. 2017 Dec 21;17(1):877. doi: 10.1186/s12885-017-3819-y.
5
Gadoxetate-enhanced abbreviated MRI is highly accurate for hepatocellular carcinoma screening.
Eur Radiol. 2020 Nov;30(11):6003-6013. doi: 10.1007/s00330-020-07014-1. Epub 2020 Jun 25.
6
Can Abbreviated Cardiac Magnetic Resonance Imaging Adequately Support Clinical Decision Making After Repair of Tetralogy of Fallot?
Pediatr Cardiol. 2019 Mar;40(3):616-622. doi: 10.1007/s00246-018-2035-0. Epub 2018 Dec 11.
7
Magnetic Resonance Imaging Is Cost-Effective for Hepatocellular Carcinoma Surveillance in High-Risk Patients With Cirrhosis.
Hepatology. 2019 Apr;69(4):1599-1613. doi: 10.1002/hep.30330. Epub 2019 Feb 25.
8
Frequency and Outcomes of Abnormal Imaging in Patients With Cirrhosis Enrolled in a Hepatocellular Carcinoma Surveillance Program.
Liver Transpl. 2019 Mar;25(3):369-379. doi: 10.1002/lt.25398.
9
The utility of gadoxetic acid-enhanced magnetic resonance imaging in the surveillance for postoperative recurrence of hepatocellular carcinoma.
Medicine (Baltimore). 2016 Dec;95(51):e5666. doi: 10.1097/MD.0000000000005666.
10
Surveillance and diagnosis of hepatocellular carcinoma: A systematic review.
World J Clin Cases. 2019 Aug 26;7(16):2269-2286. doi: 10.12998/wjcc.v7.i16.2269.
引用本文的文献
1
Comparative Analysis of Imaging Modalities for Surveillance on Outcomes in Patients With Hepatocellular Carcinoma.
Gastro Hep Adv. 2025 May 16;4(9):100704. doi: 10.1016/j.gastha.2025.100704. eCollection 2025.
2
LI-RADS: Current Status and Future Directions.
Korean J Radiol. 2024 Dec;25(12):1039-1046. doi: 10.3348/kjr.2024.0161.
3
MRI paraspinous skeletal muscle enhancement: A potential imaging biomarker for assessing clinical liver cirrhosis severity.
PLoS One. 2024 Aug 22;19(8):e0308520. doi: 10.1371/journal.pone.0308520. eCollection 2024.
4
Abbreviated magnetic resonance imaging in hepatocellular carcinoma surveillance: A review.
Indian J Gastroenterol. 2024 Dec;43(6):1090-1098. doi: 10.1007/s12664-023-01511-z. Epub 2024 Mar 9.
5
Clinical Significance of Liver MR Imaging.
Magn Reson Med Sci. 2023 Apr 1;22(2):157-175. doi: 10.2463/mrms.rev.2022-0100. Epub 2023 Feb 1.
本文引用的文献
1
Gadoxetate-enhanced Abbreviated MRI for Hepatocellular Carcinoma Surveillance: Preliminary Experience.
Radiol Imaging Cancer. 2019 Nov 29;1(2):e190010. doi: 10.1148/rycan.2019190010. eCollection 2019 Nov.
2
Gadoxetate-enhanced abbreviated MRI is highly accurate for hepatocellular carcinoma screening.
Eur Radiol. 2020 Nov;30(11):6003-6013. doi: 10.1007/s00330-020-07014-1. Epub 2020 Jun 25.
3
Comparison of diagnostic performance of non-contrast MRI and abbreviated MRI using gadoxetic acid in initially diagnosed hepatocellular carcinoma patients: a simulation study of surveillance for hepatocellular carcinomas.
Eur Radiol. 2020 Aug;30(8):4150-4163. doi: 10.1007/s00330-020-06754-4. Epub 2020 Mar 12.
4
Non-enhanced magnetic resonance imaging as a surveillance tool for hepatocellular carcinoma: Comparison with ultrasound.
J Hepatol. 2020 Apr;72(4):718-724. doi: 10.1016/j.jhep.2019.12.001. Epub 2019 Dec 10.
5
Hepatocellular carcinoma detection in liver cirrhosis: diagnostic performance of contrast-enhanced CT vs. MRI with extracellular contrast vs. gadoxetic acid.
Eur Radiol. 2020 Feb;30(2):1020-1030. doi: 10.1007/s00330-019-06458-4. Epub 2019 Oct 31.
6
Genome-wide mapping of 5-hydroxymethylcytosines in circulating cell-free DNA as a non-invasive approach for early detection of hepatocellular carcinoma.
Gut. 2019 Dec;68(12):2195-2205. doi: 10.1136/gutjnl-2019-318882. Epub 2019 Jul 29.
7
Abbreviated-protocol screening MRI vs. complete-protocol diagnostic MRI for detection of hepatocellular carcinoma in patients with cirrhosis: An equivalence study using LI-RADS v2018.
J Magn Reson Imaging. 2020 Feb;51(2):415-425. doi: 10.1002/jmri.26835. Epub 2019 Jun 18.
8
Cost-Utility Analysis of Imaging for Surveillance and Diagnosis of Hepatocellular Carcinoma.
AJR Am J Roentgenol. 2019 Jul;213(1):17-25. doi: 10.2214/AJR.18.20341. Epub 2019 Apr 17.
9
GALAD Score for Hepatocellular Carcinoma Detection in Comparison with Liver Ultrasound and Proposal of GALADUS Score.
Cancer Epidemiol Biomarkers Prev. 2019 Mar;28(3):531-538. doi: 10.1158/1055-9965.EPI-18-0281. Epub 2018 Nov 21.
10
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma.
J Hepatol. 2018 Jul;69(1):182-236. doi: 10.1016/j.jhep.2018.03.019. Epub 2018 Apr 5.
Zotero 插件